Clopidogrel benefits survivors of ST-segment elevation myocardial infarction
This article has no abstract so we have provided the first paragraph of the full text.
Antiplatelet therapy with aspirin is the standard care for patients with ST-segment elevation myocardial infarction (STEMI). Notably, addition of clopidogrel augments the effects of aspirin in patients with acute coronary syndromes without ST-segment elevation. Zeymer et al. analyzed 5,886 survivors of STEMI from the German ACOS registry, and compared a clopidogrel plus aspirin regimen with aspirin alone.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Nucleotides and cd39: Principal modulatory players in hemostasis and thrombosisNature Medicine News and Views (01 Sep 1999)
